• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Healthcare·GIANLIFE.BO
Share

Gian Life Care Limited Stocks

₹ 4.26Last Updated 22.10.2026

Issuer Rating

3/7
Performance

Modest

Risk

Considerable

Recommendation

Sell

Market Cap

₹ 494388.96507

₹ 4.26
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Gian Life Care Limited, operating under the symbol GIANLIFE.BO, delivers a range of medical testing and related health services. The company's offerings encompass both the identification of existing illnesses in patients and comprehensive preventative and wellness evaluations. It serves a diverse clientele, including individual consumers, hospitals, various other healthcare facilities, and corporate entities. Established on November 6, 2018, Gian Life Care is headquartered in Kanpur, India.

Company Valuation

Fairly valued
4/7

Based on key historical and expected multiples, the stock is fairly valued relative to its peers. In particular, the stock is 'expensive' on EV/EBITDA.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

23.10.2026 14:02

Gucci's parent company's stock plummeted by more than 10% due to a decline in sales

23.10.2026 13:03

The price of Brent crude oil exceeded $114 for the first time since May

23.10.2026 12:41

An Angry France: What Surprises Might Lie Ahead in the Upcoming Presidential Election?

23.10.2026 12:14

OpenAI had to lower its target valuation from $1.4 trillion to $1.25 trillion. Where did all the hype go?

23.10.2026 11:44

Kazakhstan's first "AI unicorn" has attracted investment from Nvidia

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026